Skip to main
SNWV
SNWV logo

SNWV Stock Forecast & Price Target

SNWV Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SANUWAVE Health Inc. demonstrated significant financial growth in 2024, achieving a remarkable 60% year-over-year increase in revenue, totaling $32.6 million, primarily fueled by both system sales and consumables. The company also reported a substantial improvement in profitability, with adjusted EBITDA rising by 28 percentage points to reach +22%. While operating expenses increased by $1.1 million, largely due to non-cash stock-based compensation, the overall financial performance reflects a strong upward trend and positions SANUWAVE favorably within its industry.

Bears say

SANUWAVE Health has experienced a decline in applicator usage during the first quarter, a trend attributed to typical seasonal behavior as patients postpone treatments following the reset of annual insurance deductibles in January. Additionally, the company faces several challenges that may adversely affect its stock performance, including margin compression, reduced productivity among sales representatives, and competitive pressures. There are concerns over potential manufacturing setbacks that could further hinder operational efficiency and sales growth.

SNWV has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SANUWAVE Health Inc (SNWV) Forecast

Analysts have given SNWV a Buy based on their latest research and market trends.

According to 2 analysts, SNWV has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SANUWAVE Health Inc (SNWV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.